Babesia microti Antibodies, IgG and IgM by IFA
0093048
Ordering Recommendation
 
Mnemonic
BAB MIC AB
Methodology
Semi-Quantitative Indirect Fluorescent Antibody
Performed
Wed
Reported
1-9 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Serum separator tube. Also acceptable: Lavender (EDTA), green (heparin), and yellow (ACD).  
Specimen Preparation
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.1 mL) Parallel testing is preferred, and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimens plainly as "acute" or "convalescent."  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Bacterially contaminated, hemolyzed or lipemic specimens.  
Remarks
  
Stability
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)  
Reference Interval
 
 
Test Number Components Reference Interval
0093049Babesia microti Antibody, IgG by IFA < 1:16 Negative -​ No significant level of detectable Babesia IgG antibody.
1:16  Equivocal -​  Repeat testing in 10-​14 days may be helpful.
> 1:16  Positive -​ IgG antibody to Babesia detected, which may indicate a current or past infection.
0093050Babesia microti Antibody, IgM by IFA < 1:20  Negative -​ No significant level of detectable Babesia IgM antibody.
1:20  Equivocal -​ Repeat testing in 10-​14 days may be helpful.
> 1:20  Positive -​ IgM antibody to Babesia detected, which may indicate a current or recent infection.
Interpretive Data


See Compliance Statement A: www.aruplab.com/CS
Statement A: Analyte specific reagents (ASR) are used in many laboratory tests necessary for standard medical care and generally do not require U.S. Food and Drug Administration (FDA) approval or clearance. This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. This test should not be regarded as investigational or for research use.
 
Note
 
CPT Code(s)
86753 x2
Components
Component Test Code*Component Chart NameLOINC
0093049Babesia microti IgG16117-4
0093050Babesia microti IgM16118-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • B microti Ab
  • B microti Ab panel
  • Babesia microti Antibodies (IgG, IgM)
  • Babesia Microti IgG/IgM Ab Panel
  • Babesiosis Serology